Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | ITGB3 | P05106 | 3/20 | 0.32 |
| ▸ | ITGAV | P06756 | 3/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.31 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.31 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.31 |
| ▸ | GNPAT | O15228 | 1/20 | 0.30 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8424379 | 1.00 | CAMK2A (0.33) | CAMK2APTGS1KCNH2ITGB3ITGAV | |
| SCHEMBL28308288 | 0.94 | GPR84 (0.34) | CAMK2AGPR84FFAR1FFAR4CPB2 | |
| SCHEMBL8634866 | 0.93 | GPR84 (0.38) | CAMK2AGPR84FFAR1FFAR4 | |
| SCHEMBL5144359 | 0.88 | GABRR1 (0.32) | ITGB3ITGAVALDH1A1LMNAGABRR1 | |
| SCHEMBL4030392 | 0.88 | GABRR1 (0.32) | ITGB3ITGAVALDH1A1LMNAGABRR1 | |
| SCHEMBL4553554 | 0.88 | GABRR1 (0.32) | ITGB3ITGAVALDH1A1LMNAGABRR1 | |
| SCHEMBL1374080 | 0.86 | ECE1 (0.36) | PTGS1KCNH2 | |
| SCHEMBL1374076 | 0.86 | ECE1 (0.36) | PTGS1KCNH2 | |
| SCHEMBL2910202 | 0.84 | CA2 (0.39) | CAMK2ACPB2GNPAT | |
| SCHEMBL2910205 | 0.84 | CA2 (0.39) | CAMK2ACPB2GNPAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011059779-A2 | LIGAND-TARGETED MULTI- STEREOISOMER PEPTIDE POLYMER CONJUGATES AND USES THEREOF | GONZALEZ LUCIA IRENE (US) | 2011-05-19 | — | — | WO | claimed |
| US-20110104783-A1 | STEREOISOMER PEPTIDES, LIGAND-TARGETED MULTI- STEREOISOMER PEPTIDE POLYMER CONJUGATES, AND USES THEREOF | GONZALEZ LUCIA IRENE | 2011-05-05 | — | — | US | claimed |
| US-9790286-B2 | Stereoisomer peptides, their polymer conjugates, their encapsulation into nanoparticles, and uses thereof for the treatment of diseases caused by abnormal angiogenesis | GONZALEZ LUCIA IRENE (US) | 2017-10-17 | — | — | US | disclosed |
| US-20150050351-A1 | STEREOISOMER PEPTIDES, THEIR POLYMER CONJUGATES, THEIR ENCAPSULATION INTO NANOPARTICLES, AND USES THEREOF FOR THE TREATMENT OF DISEASES CAUSED BY ABNORMAL ANGIOGENESIS. | GONZALEZ LUCIA IRENE (US) | 2015-02-19 | — | — | US | disclosed |
| US-8906355-B2 | Synthetic stereoisomer peptides in the retro-inverso and inverso configuration, and with cyclic and linear structure, their polymer conjugates, their encapsulation in polymer particles, and uses thereof | GONZALEZ LUCIA IRENE (US) | 2014-12-09 | — | — | US | disclosed |
| US-8715986-B2 | Stereoisomer peptides, ligand-targeted multi- stereoisomer peptide polymer conjugates, and uses thereof | GONZALEZ LUCIA IRENE (US) | 2014-05-06 | — | — | US | disclosed |
| US-20130156723-A1 | SYNTHETIC STEREOISOMER PEPTIDES IN THE RETRO-INVERSO AND INVERSO CONFIGURATION, AND WITH CYCLIC AND LINEAR STRUCTURE, THEIR POLYMER CONJUGATES, THEIR ENCAPSULATION IN POLYMER PARTICLES, AND USES THEREOF | GONZALEZ LUCIA IRENE (US) | 2013-06-20 | — | — | US | disclosed |
| WO-2011059779-A2 | LIGAND-TARGETED MULTI- STEREOISOMER PEPTIDE POLYMER CONJUGATES AND USES THEREOF | GONZALEZ LUCIA IRENE (US) | 2011-05-19 | — | — | WO | disclosed |
| US-20110104783-A1 | STEREOISOMER PEPTIDES, LIGAND-TARGETED MULTI- STEREOISOMER PEPTIDE POLYMER CONJUGATES, AND USES THEREOF | GONZALEZ LUCIA IRENE | 2011-05-05 | — | — | US | disclosed |
| EP-1487493-A4 | CONJUGATES OF THERAPEUTIC OR CYTOTOXIC AGENTS AND BIOLOGICALLY ACTIVE PEPTIDES | UNIV TULANE (US) | 2006-08-30 | — | — | EP | disclosed |
| EP-1487493-A2 | CONJUGATES OF THERAPEUTIC OR CYTOTOXIC AGENTS AND BIOLOGICALLY ACTIVE PEPTIDES | The Administrators of The Tulane Educational Fund (US) | 2004-12-22 | — | — | EP | disclosed |
| WO-2003074551-A2 | CONJUGATES OF THERAPEUTIC OR CYTOTOXIC AGENTS AND BIOLOGICALLY ACTIVE PEPTIDES | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 2003-09-12 | — | — | WO | disclosed |